Neuromedin U Receptor 1 Antibodies

The neuromedin U receptor 1 (NMU1) is a G protein–coupled receptor that plays an important role in regulating smooth muscle contraction, nociception, and energy balance. It is predominantly localized on the plasma membrane of peripheral tissues, especially in the gastrointestinal tract, where it is expressed in enteric neurons and smooth muscle cells, as well as in certain regions of the central nervous system. This cellular localization enables NMU1 to mediate rapid responses to its endogenous ligand, neuromedin U, leading to intracellular calcium release and activation of downstream signaling pathways. In peripheral tissues, NMU1 activation is associated with modulation of gut motility and secretion, while in the nervous system it contributes to stress responses and pain signaling. Its presence in immune-related cells also suggests a role in inflammatory processes. From a pharmacological perspective, NMU1 represents a promising target for the development of drugs aimed at metabolic disorders, gastrointestinal dysfunction, and inflammatory diseases. Several synthetic agonists, such as peptide-based NMU analogs, have been developed to selectively activate NMU1 and mimic endogenous signaling. In addition, early-stage antagonists and small-molecule modulators are being investigated to block receptor activity and attenuate pathological signaling. For more information on NMU1 receptor pharmacology please refer to the IUPHAR database. For further reading refer to:

Al-hosaini K, Bloom SR, Hedrick J, Howard A, Jethwa P, Luckman S, Raddatz R, Semjonous N, Willars GB. Neuromedin U receptors in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023; 2023(1). Available from: https://doi.org/10.2218/gtopdb/F42/2023.1.